Cargando…
A FASII Inhibitor Prevents Staphylococcal Evasion of Daptomycin by Inhibiting Phospholipid Decoy Production
Daptomycin is a treatment of last resort for serious infections caused by drug-resistant Gram-positive pathogens, such as methicillin-resistant Staphylococcus aureus. We have shown recently that S. aureus can evade daptomycin by releasing phospholipid decoys that sequester and inactivate the antibio...
Autores principales: | Pee, Carmen J. E., Pader, Vera, Ledger, Elizabeth V. K., Edwards, Andrew M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6496159/ https://www.ncbi.nlm.nih.gov/pubmed/30718253 http://dx.doi.org/10.1128/AAC.02105-18 |
Ejemplares similares
-
Enterococcus faecalis and pathogenic streptococci inactivate daptomycin by releasing phospholipids
por: Ledger, Elizabeth V. K., et al.
Publicado: (2017) -
Identification of Antifungal H(+)-ATPase Inhibitors with Effect on Plasma Membrane Potential
por: Kjellerup, Lasse, et al.
Publicado: (2017) -
Host Cell Metabolism Contributes to Delayed-Death Kinetics of Apicoplast Inhibitors in Toxoplasma gondii
por: Amberg-Johnson, Katherine, et al.
Publicado: (2019) -
A Novel High-Content Phenotypic Screen To Identify Inhibitors of Mitochondrial DNA Maintenance in Trypanosomes
por: Miskinyte, Migla, et al.
Publicado: (2022) -
Novel Bacterial Topoisomerase Inhibitor Gepotidacin Demonstrates Absence of Fluoroquinolone-Like Arthropathy in Juvenile Rats
por: Fishman, Cindy, et al.
Publicado: (2022)